🇨🇦 Standard of Care: Cyclophosphamide in Canada

Standard of Care: Cyclophosphamide (Standard of Care: Cyclophosphamide) regulatory status in Canada.

Marketing authorisation

Standard of Care: Cyclophosphamide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Standard of Care: Cyclophosphamide approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Standard of Care: Cyclophosphamide in Canada?

H. Lee Moffitt Cancer Center and Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.